Resources

Learn more

• National Blood Authority: Immunoglobulin products in clinical practice

• Blood Matters Subcutaneous immunoglobulin (SCIg) program

• BloodSafe eLearning: Immunoglobulin

​

Recent peer reviewed articles

• Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy - McQuilten et al. (2024)

• Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies - Carrillo de Albornoz et al. (2024)

• A systematic review of the cost and cost-effectiveness of immunoglobulin treatment in patients with hematological malignancies - Carrillo de Albornoz et al. (2024)

• Variation in immunoglobulin use and impact on survival in myeloma - Chai et al. (2024)

• Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis - Chai et al. (2023)

• Epidemiology of Kawasaki disease in Australia using two nationally complete datasets - Lucas et al. (2022)

• Variation in the management of Kawasaki disease in Australia and New Zealand: A survey of paediatricians - Lucas et al. (2021)

​

Consumer organisations

• Myeloma Australia

• Lymphoma Australia

• Kawasaki Disease Foundation Australia

• Myasthenia Alliance Australia

  • Myasthenia Gravis Association of Queensland Inc.​

  • The Australian Myasthenic Association in NSW Inc.

​​

Our research

• VALUE-MG

• VALUE-Ig

• RATIONALISE

• RATIONAL: Ig platform trial

• Blood Synergy